Position in ONC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$355,473
+$69,284 QoQ
Shares Held
1,197
+27.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Snowden Capital Advisors LLC holds $12,608,129 across 22 Biotechnology names. ONC ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,864 | $2,212,840 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,833 | $1,711,587 | |
| 3 | ARGX |
Argenx SE
|
2,117 | $1,545,939 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,383 | $1,247,429 | |
| 5 | INSM |
INSMED Inc
|
7,571 | $1,238,009 | |
| 6 | MRNA |
Moderna, Inc.
|
12,722 | $646,277 | |
| 7 | IDYA |
IDEAYA Biosciences, Inc.
|
19,231 | $640,776 | |
| 8 | ONC |
BeOne Medicines Ltd.
This page
|
1,197 | $355,473 |
All Filings in ONC
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $355,473 | 1,197 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $286,189 | 942 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $337,633 | 991 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $223,430 | 923 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $243,864 | 896 | Shares | Sole | 2025-05-14 | |
| 2024-09-30 | $215,754 | 961 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||